Biotechnology Letters

, Volume 28, Issue 20, pp 1633–1636 | Cite as

Sclerotiorin, from Penicillium frequentans, a potent inhibitor of aldose reductase

  • C. Chidananda
  • L. Jagan Mohan Rao
  • A. P. Sattur
Original Paper

Abstract

Aldose reductase, the first key enzyme in the polyol pathway, is involved in complications of diabetes. Sclerotiorin, isolated and purified from the fermented broth of Penicillium frequentans, inhibited aldose reductase with an IC50 0.4 µM. The inhibitor also showed antibacterial activity against Bacillus spp.

Keywords

Aldose reductase Diabetes Hyperglycemia Inhibitor Penicillium frequentans Sclerotiorin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgements

The authors thank the Director, CFTRI, Mysore, for providing facilities and Department of Biotechnology, New Delhi, India, for awarding grant to conduct this research work. Chidananda C is thankful for Council of Scientific and Industrial Research, New Delhi, India, for the award of senior research fellowship.

References

  1. Arai N, Shiomi K, Tomoda H, Tabata N, Yang DJ, Masuma R, Kawakubo T, Omura S (1995) Isochromophilones III–VI, inhibitors of acyl–CoA: cholesterol acyltransferase produced by Penicillium multicolor FO-3216. J Antibiot 48:696–702PubMedGoogle Scholar
  2. Curtin TP, Reilly J (1940) Sclerotiorin, C20H20O5Cl, a chlorine-containing metabolic product of Penicillium sclerotiorum van Beyma. Biochem J 34:1419–1421Google Scholar
  3. Fujimoto H., Matsudo T, Yamaguchi A, Yamazaki M (1990) Two new fungal azaphilones from Talaromyces luteus, with monoamine oxidase inhibitory effect. Heterocycles 30:607–616CrossRefGoogle Scholar
  4. Kador PE (1998) The role of aldose reductase in the development of diabetic complications. Med Res Rev 8:325–352CrossRefGoogle Scholar
  5. Kador PE, Robinson WG, Kinoshita JH (1985) The pharmacology of aldose reductase inhibitors. Ann Rev Pharmacol Toxicol 25:691–714CrossRefGoogle Scholar
  6. Kim HY, Oh JH (1999) Screening of Korean forest plants for rat lens aldose reductase inhibition. Biosci Biotechnol Biochem 63:184–188PubMedCrossRefGoogle Scholar
  7. Omura S, Tanaka H, Matsuzaki K, Ikeda H, Masuma R (1993) Isochromophilones I and II, novel inhibitors against gp120-CD4 binding from Penicillium sp. J Antibiot 46:1908–1911PubMedGoogle Scholar
  8. Owais M, Sharad KS, Shehbaz A, Saleemuddin M (2005) Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine Salmonellosis. Phytomedicine 12:229–235PubMedCrossRefGoogle Scholar
  9. Pairet L, Wrigley SK, Chetland I, Reynolds EE, Hayes MA, Holloway J, Ainsworth AM, Katzer W, Cheng X-M, Hupe DJ, Charlton P, Doherty AM (1995) Azaphilones with endothelin receptor binding activity produced by Penicillium sclerotiorum: taxonomy, fermentation, isolation, structural elucidation and biological activity. J Antibiot 48:913–923PubMedGoogle Scholar
  10. Rao KCS, Divakar S, Babu KN, Karanth NG, Sattur AP (2002) Nigerloxin, a novel inhibitor of aldose reductase and lipoxygenase with free radical scavenging activity from Aspergillus niger CFR-W-105. J Antibiot 55:789–793PubMedGoogle Scholar
  11. Rao KCS, Divakar S, Srinivas M, Babu KN, Karanth NG, Sattur AP (2003) Asperaldin, a new aldose reductase inhibitor from Aspergillus niger CFR-1046. J Antibiot 56:173–176PubMedGoogle Scholar
  12. Tomoda H, Matsushima C, Tabata N, Namatame I, Tanaka H, Bamberger MJ, Arai H, Fukazawa M, Inoue K, Omura S (1999) Structure-specific inhibition of cholesteryl ester transfer protein by azaphilones. J Antibiot 52:160–170PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • C. Chidananda
    • 1
  • L. Jagan Mohan Rao
    • 1
  • A. P. Sattur
    • 1
  1. 1.Fermentation Technology and Bioengineering DepartmentCentral Food Technological Research InstituteMysoreIndia

Personalised recommendations